Apigenin inhibits TGF-β-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism. (Q54453412)

30 May 2018

title

Apigenin inhibits TGF-β-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism. (English)

1 reference

30 May 2018

main subject

apigenin

1 reference

ChEBI release 2020-05-28

1 reference

Salida Mirzoeva

1

1 reference

30 May 2018

Carrie A Franzen

series ordinal

2

1 reference

30 May 2018

Jill C Pelling

series ordinal

3

1 reference

30 May 2018

publication date

28 January 2013

1 reference

30 May 2018

published in

Molecular Carcinogenesis

1 reference

30 May 2018

volume

53

1 reference

30 May 2018

issue

8

1 reference

30 May 2018

page(s)

598-609

1 reference

30 May 2018

Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study

cites work

1 reference

Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications

21 January 2018

1 reference

Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy

21 January 2018

1 reference

Growth factors involved in prostate carcinogenesis.

21 January 2018

1 reference

Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression

21 January 2018

1 reference

Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells.

21 January 2018

1 reference

Apigenin: a promising molecule for cancer prevention

21 January 2018

1 reference

Vascular endothelial growth factor (VEGF) signaling in tumor progression

21 January 2018

1 reference

Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.

21 January 2018

1 reference

Blockade of transforming growth factor‐beta (TGFβ) signaling inhibits osteoblastic tumorigenesis by a novel human prostate cancer cell line

21 January 2018

1 reference

The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism

21 January 2018

1 reference

Inhibition of Src kinase activity by Ad-mda7 suppresses vascular endothelial growth factor expression in prostate carcinoma cells

21 January 2018

1 reference

c-Src and cooperating partners in human cancer

21 January 2018

1 reference

HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas.

21 January 2018

1 reference

Role of Src expression and activation in human cancer

21 January 2018

1 reference

A tail of two src's: mutatis mutandis

21 January 2018

1 reference

Signaling through focal adhesion kinase

21 January 2018

1 reference

Adhesion-linked kinases in cancer; emphasis on src, focal adhesion kinase and PI 3-kinase

21 January 2018

1 reference

Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases

21 January 2018

1 reference

Prostate cancer mediates osteoclastogenesis through two different pathways

21 January 2018

1 reference

TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways

21 January 2018

1 reference

Smad3 mediates TGF-beta1 induction of VEGF production in lung fibroblasts.

21 January 2018

1 reference

Angiogenesis-dependent diseases

21 January 2018

1 reference

Tumoral angiogenesis: review of the literature

21 January 2018

1 reference

Dietary flavonoids: bioavailability, metabolic effects, and safety

21 January 2018

1 reference

Chemoprevention of photocarcinogenesis by selected dietary botanicals

21 January 2018

1 reference

Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression

21 January 2018

1 reference

Molecular targets for apigenin-induced cell cycle arrest and apoptosis in prostate cancer cell xenograft.

21 January 2018

1 reference

Effect of flavonoids on cell cycle progression in prostate cancer cells

21 January 2018

1 reference

The role of Src in prostate cancer

21 January 2018

1 reference

Regulation of angiogenesis and vascular permeability by Src family kinases: opportunities for therapeutic treatment of solid tumors.

21 January 2018

1 reference

Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK.

21 January 2018

1 reference

Involvement of cell-cell interactions in the rapid stimulation of Cas tyrosine phosphorylation and Src kinase activity by transforming growth factor-beta 1.

21 January 2018

1 reference

Transforming growth factor-beta1-dependent urokinase up-regulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells

21 January 2018

1 reference

Src activation is not necessary for transforming growth factor (TGF)-beta-mediated epithelial to mesenchymal transitions (EMT) in mammary epithelial cells. PP1 directly inhibits TGF-beta receptors I and II.

21 January 2018

1 reference

Targeting TGF-beta in prostate cancer: therapeutic possibilities during tumor progression

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MC.22005

1 reference

30 May 2018

1 reference

30 May 2018